---
description: Learn more about EquiReason price, benefits, and disadvantages for businesses in South Africa. Read reviews from verified users and discover similar tools.
image: https://gdm-localsites-assets-gfprod.imgix.net/images/capterra/og_logo-e5a8c001ed0bd1bb922639230fcea71a.png?auto=format%2Cenhance%2Ccompress
title: EquiReason Price, Reviews & Features - Capterra South Africa 2026
---

Breadcrumb: [Home](/) > [Investment Management Software](/directory/20010/investment-management/software) > [EquiReason](/software/1322277/EquiReason)

# EquiReason

Canonical: https://www.capterra.co.za/software/1322277/EquiReason

> Equity research that reads every SEC filing and holds an evidence-backed verdict on each company. Free plan for every company.
> 
> Verdict: Rated \*\*\*\* by 0 users. Top-rated for **Overall Quality**.

-----

## Overview

### Who Uses EquiReason?

Thesis-driven individual investors, independent analysts and small research teams who want primary-source equity research without a research department of their own.

## About the vendor

- **Company**: EquiReason

## Commercial Context

- **Pricing model**:  (Free version available) (Free Trial)
- **Pricing Details**: Free: $0 forever — the filed record for every company: financial statements for every year, quarterly series, segment and KPI history, every SEC filing with a plain-language summary, 13F, insider and 13D/13G ownership, two followed companies with alerts, and one full verdict per month. Analyst: $49/month or $490/year — our verdict, score, reasons and counter-thesis on every covered company, earnings quality, valuation against peers, the trend board, estimates, short interest and options positioning, a 50-company watchlist and alerts. Research Pro: $89/month or $890/year — the full research department. Teams \& Data: contact us. Annual billing is ten months for twelve. Research Pro can be tried free for seven days, no card required. Every company is open on every plan.
- **Target Audience**: Self Employed, 2–10, 11–50
- **Deployment & Platforms**: Cloud, SaaS, Web-based
- **Supported Languages**: English
- **Available Countries**: Australia, Canada, Germany, India, Netherlands, Singapore, Türkiye, United Kingdom, United States

## Features

- Financial Analysis

## Support Options

- Email/Help Desk
- FAQs/Forum
- Knowledge Base

## Category

- [Investment Management Software](https://www.capterra.co.za/directory/20010/investment-management/software)

## Alternatives

1. [Morningstar Direct](https://www.capterra.co.za/software/1074481/Morningstar-Direct) — 4.1/5 (278 reviews)
2. [Agicap](https://www.capterra.co.za/software/196637/agicap) — 4.3/5 (161 reviews)
3. [Creatio AI CRM](https://www.capterra.co.za/software/130149/creatio-ai-crm) — 4.7/5 (151 reviews)
4. [Foundersuite](https://www.capterra.co.za/software/144844/foundersuite) — 4.7/5 (110 reviews)
5. [Plaid](https://www.capterra.co.za/software/174384/plaid) — 4.4/5 (110 reviews)

## Links

- [View on Capterra](https://www.capterra.co.za/software/1322277/EquiReason)

## This page is available in the following languages

| Locale | URL |
| en | <https://www.capterra.com/p/10267105/EquiReason/> |
| en-AE | <https://www.capterra.ae/software/1322277/EquiReason> |
| en-AU | <https://www.capterra.com.au/software/1322277/EquiReason> |
| en-CA | <https://www.capterra.ca/software/1322277/EquiReason> |
| en-GB | <https://www.capterra.co.uk/software/1322277/EquiReason> |
| en-IE | <https://www.capterra.ie/software/1322277/EquiReason> |
| en-IL | <https://www.capterra.co.il/software/1322277/EquiReason> |
| en-IN | <https://www.capterra.in/software/1322277/EquiReason> |
| en-NZ | <https://www.capterra.co.nz/software/1322277/EquiReason> |
| en-SG | <https://www.capterra.com.sg/software/1322277/EquiReason> |
| en-ZA | <https://www.capterra.co.za/software/1322277/EquiReason> |

-----

## Structured Data

<script type="application/ld+json">
  {"@context":"https://schema.org","@graph":[{"name":null,"address":{"@type":"PostalAddress","addressLocality":null,"addressRegion":null,"postalCode":null,"streetAddress":null},"description":"Capterra South Africa helps find the best business software. With software reviews, ratings, infographics and a comprehensive list of business software.","email":"info@capterra.co.za","url":"https://www.capterra.co.za/","logo":"https://dm-localsites-assets-prod.imgix.net/images/capterra/logo-a9b3b18653bd44e574e5108c22ab4d3c.svg","@id":"https://www.capterra.co.za/#organization","@type":"Organization","parentOrganization":"G2.com, Inc.","sameAs":["https://twitter.com/capterra","https://www.facebook.com/Capterra/","https://www.linkedin.com/company/capterra","https://www.instagram.com/capterra/","https://www.youtube.com/user/CapterraTV"]},{"name":"EquiReason","description":"EquiReason is an equity research and market intelligence platform that runs like a full research department. It reads SEC filings, earnings transcripts, macro data and positioning; works out what is changing in the world and which economic mechanism carries it to which companies; and holds a verdict on every covered company with the evidence for and against it — refreshed the moment something changes, with the underlying data open to those who want it. It reads primary sources directly: 10-K, 10-Q and 8-K filings, Form 4 insider transactions, 13F institutional holdings and XBRL financial data from SEC EDGAR. Every company is open on every plan, including a free plan with financial statements, filings and ownership for every company. EquiReason is a research and decision-support tool; it does not provide investment advice.","image":"https://images.g2crowd.com/display-layer-screenshots/2142400/facd991e1e69d767bb83b75f3b04be9654716476537a688c42a4f55ffaa980c8.png","url":"https://www.capterra.co.za/software/1322277/EquiReason","@id":"https://www.capterra.co.za/software/1322277/EquiReason#software","@type":"SoftwareApplication","applicationCategory":"BusinessApplication","publisher":{"@id":"https://www.capterra.co.za/#organization"},"operatingSystem":"Cloud"},{"@id":"https://www.capterra.co.za/software/1322277/EquiReason#faqs","@type":"FAQPage","mainEntity":[{"name":"What Is EquiReason?","@type":"Question","acceptedAnswer":{"text":"EquiReason is an equity research and market intelligence platform that runs like a full research department. It reads SEC filings, earnings transcripts, macro data and positioning; works out what is changing in the world and which economic mechanism carries it to which companies; and holds a verdict on every covered company with the evidence for and against it — refreshed the moment something changes, with the underlying data open to those who want it. It reads primary sources directly: 10-K, 10-Q and 8-K filings, Form 4 insider transactions, 13F institutional holdings and XBRL financial data from SEC EDGAR. Every company is open on every plan, including a free plan with financial statements, filings and ownership for every company. EquiReason is a research and decision-support tool; it does not provide investment advice.","@type":"Answer"}},{"name":"Who Uses EquiReason?","@type":"Question","acceptedAnswer":{"text":"Thesis-driven individual investors, independent analysts and small research teams who want primary-source equity research without a research department of their own.","@type":"Answer"}}]},{"@id":"https://www.capterra.co.za/software/1322277/EquiReason#breadcrumblist","@type":"BreadcrumbList","itemListElement":[{"name":"Home","position":1,"item":"/","@type":"ListItem"},{"name":"Investment Management Software","position":2,"item":"/directory/20010/investment-management/software","@type":"ListItem"},{"name":"EquiReason","position":3,"item":"/software/1322277/EquiReason","@type":"ListItem"}]}]}
</script>